Howard Scher on the Definition of Castration-Sensitive/Naive Prostate Cancer

Howard Scher, MD, presents, "The Definition of Castration-Sensitive/Naive Prostate Cancer" at the 2017 Advanced Prostate Cancer Consensus Conference (APCCC) in St. Gallen, Switzerland.  Alicia Morgans, MD interviews Dr. Scher on how testosterone levels come into the thought process of treatment and how to measure.  Also, discussion around genomic classifications and tests if they are ready for prime time.

Biographies:
Howard I. Scher, MD is Chief of the Genitourinary Oncology Service at Memorial Sloan Kettering Cancer Center, Professor of Medicine at the Weill Cornell Medical College, and the D. Wayne Calloway Chair in Urologic Oncology. 

Alicia Morgans, MD, MPH


Access to all Advanced Prostate Cancer Consensus Conference Video Coverage

Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer



E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe